OSAGE UNIVERSITY PARTNERS OVERVIEW March 2014 University - - PowerPoint PPT Presentation

University Innovatjon, Realized.

Contact Us

50 Monument Rd, 201, Bala Cynwyd, PA 19004 +1.484.434.2255 • info@osagepartners.com CONFIDENTIAL & PROPRIETARY

OSAGE UNIVERSITY PARTNERS OVERVIEW

March 2014

2

CONFIDENTIAL & PROPRIETARY

Osage University Partners Fund I Overview -- $100 M

UNIQUE VENTURE FUND THAT PARTNERS WITH UNIVERSITIES TO INVEST IN THEIR SPIN-OUTS BY EXERCISING THEIR PARTICIPATION RIGHTS

• Osage invests in early, middle, and late stage university spinouts across all technology sectors

OSAGE HAS GROWN TO 65+ PARTNER INSTITUTIONS IN FOUR YEARS PARTNER UNIVERSITIES SHARE IN OSAGE PROFIT AND BENEFIT FROM SIGNIFICANT SUPPORT IN LAUNCHING AND PROMOTING START-UPS

• Osage provides programmatc help to TLOs and their start-ups to promote funding, hiring, strategic

partnerships, and more

• Osage holds in person University Summits with partner universites to share best practces
• Osages shares proprietary data with partners re licensing database, fjnancing trends, and more

OUP I HAS A STRONG PORTFOLIO WITH MULTIPLE EARLY EXITS

• 31 investments; 3 early IPOs, 1 M&A event ($300 million+ acquisiton price), and many more

companies maturing towards an exit

3

CONFIDENTIAL & PROPRIETARY

Partjcipatjon Rights Are the Key

Partcipaton Rights remain actve through all future rounds, even if not exercised University Partcipaton Rights provide access to a small percentage of a fjnancing so the rights do not interfere with a company’s fjnancing plan Partcipaton Rights provide shareholders a fair mechanism to protect against diluton by allowing them to invest in future fjnancing rounds Partcipaton Rights are not free: investors put up capital at the same tme, price, and terms as others in the fjnancing round Partcipaton Rights can provide access into compettve fjnancing rounds

4

CONFIDENTIAL & PROPRIETARY

Partjcipatjon Rights (to be included in licenses)

PARTICIPATION RIGHTS

If the Company proposes to sell any equity securites or securites that are convertble into equity securites of the Company, then the University and/or its Assignee (as defjned below) will have the right to purchase up to 10% of the securites issued in each ofering on the same terms and conditons as are ofered to the other purchasers in each such fjnancing. Company shall provide thirty days advanced writen notce of each such fjnancing, including reasonable detail regarding the terms and purchasers in the fjnancing. The term “Assignee” means (a) any entty to which the University’s partcipaton rights under this secton have been assigned either by the University or another entty, or (b) any entty that is controlled by the University. This paragraph shall survive the terminaton

• f this agreement.

5

CONFIDENTIAL & PROPRIETARY

Investment Focus

ALL STAGES OF NEW VENTURES BROAD RANGE OF MARKET SECTORS

$100,000 to $250,000 $500,000 to $2,000,000 $2,000,000 and $5,000,000

Cleantech & Energy Informatjon Technology Materials Seed Early Mature Life Sciences

6

CONFIDENTIAL & PROPRIETARY

Technology Investments

Advanced Materials & Semiconductors

EVOLV

Technologies

Cleantech & Energy Informatjon Technology

SurfCrew

7

CONFIDENTIAL & PROPRIETARY

Life Science Investments

ONCOLOGY CARDIOVASCULAR RESPIRATORY CNS OPHTHAMOLOGY DIAGNOSTICS GENE THERAPY DEVICES

SIDERI S

PHARMACEUTICALS

HEMATOLOGY ENT

8

CONFIDENTIAL & PROPRIETARY

Investments Diversifjed Across Stage

Seed 1st Round 4th Round + SIDERIS

PHARMACEUTICALS

EVOLV

Technologies

SurfCrew

2nd Round 3rd Round

9

CONFIDENTIAL & PROPRIETARY

Strong Group of Co-investors

10

CONFIDENTIAL & PROPRIETARY

University Partners Have Made Exclusive Assignments of Their Rights

EXCLUSIVE

Exclusive partnerships with exceptonal universites where OUP is assigned all Partcipaton Rights on existng and future companies for duraton of fund, subject to 50% co-investment by universites

DEEP COVERAGE

Close working partnership with each university allows OUP to track company progress from an early stage to evaluate company progress

EXPANSION

For Fund II, Osage will more than double the number

• f university partners

UNIVERSITY PARTNERS IN OUP I PROFIT SHARING

OUP shares part of its carry with universites in exchange for access to partcipaton rights

11

CONFIDENTIAL & PROPRIETARY

Associate Partners

DEAL SPECIFIC

Proprietary relatonships that provide company specifjc Partcipaton Rights and profjt sharing

BROAD COVERAGE

Broadens sector and stage balance of investment

• pportunites, allowing for

complete coverage of the entre university startup landscape

EXPANSION

Contnue to expand to new universites, research insttutons, and non- traditonal research centers

OUP signed 60 Associate Partners during the fjrst three years of OUP I

z z

12

CONFIDENTIAL & PROPRIETARY

Contact Us

SUMMARY

Osage University Partners (OUP) invests in startups that have licensed technologies from universites and research

• insttutons. OUP has partnered with over 65 academic insttutons to invest in pioneering technologies and visionary

entrepreneurs targetng large market opportunites. The Fund invests across a range of technology sectors and company stages, and typically co-invests with other leading venture funds.

University Innovatjon, Realized.

PERSONNEL

Name

Title Email

Robert Adelson

Managing Partner radelson@osagepartners.com

Louis Berneman

Founding Partner lberneman@osagepartners.om

Sudip Chakrabart

Vice President sudip@osagepartners.com

Mathew Cohen

Associate mcohen@osagepartners.com

William Harrington

Managing Partner bharrington@osagepartners.com

Bryce Istvan

Analyst bistvan@osagepartners.com

John Lee

Associate jlee@osagepartners.com

Martn Lehr

Senior Associate mlehr@osagepartners.com

Marc Singer

Managing Partner msinger@osagepartners.com

Contact Us

50 Monument Rd, Suite 201 Bala Cynwyd, PA 19004 484.434.2255 www.osageuniversitypartners.com